Company
Coya Therapeutics, Inc. (COYA)
Standardized SEC financial data for Coya Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001835022 · NASDAQ · Pharmaceutical Preparations.
Operating margin
-283.9%
Net margin
-267.1%
Revenue growth (YoY)
123.6%
Return on equity
-49.3%
Free cash flow
-$10.7M
Current ratio
8.51×
EPS (diluted)
$-1.27
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $0 | $6.0M | $3.6M | $7.9M |
| R&D expense | $2.5M | $4.4M |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | — | $4.3M | $5.9M | $32.6M | $38.3M | $46.8M |
| Total current assets |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$3.9M | -$7.2M | -$11.2M | -$10.3M | -$10.7M |
| Investing cash flow | -$137K | -$525K |
Get COYA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/COYA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/COYA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"